News

Vaxart, Inc. a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has signed an…
Read More...

Algernon Pharmaceuticals Inc. a clinical stage pharmaceutical development company, announces that it has reached 70% of its enrollment target for its Phase 2 clinical study of its…
Read More...

Eureka Therapeutics, Inc. announced that Eureka and Memorial Sloan Kettering Cancer Center (MSK) entered into a license agreement with Sanofi for the non-CAR use of a novel, human…
Read More...

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products for patients in Greater China and other parts of Asia,…
Read More...

Altogen Labs, a preclinical CRO, provides essential safety and efficacy testing for novel medicines (GLP-compliant pharm/tox assays per FDA IND requirements). Company works with…
Read More...

Standigm Inc. a leading workflow artificial intelligence (AI) drug discovery company, and SK Chemicals Co., Ltd a life science and green chemicals company, announced today that they…
Read More...

GlaxoSmithKline plc and Alector announced a strategic global collaboration for the development and commercialisation of two clinical-stage, potential first-in-class monoclonal…
Read More...

Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing a new research collaboration with Prof.…
Read More...

Philip Morris International Inc. announced it has entered into an agreement to acquire Fertin Pharma A/S (Fertin Pharma), a leading developer and manufacturer of innovative…
Read More...

Seres Therapeutics, Inc. announced that it has entered into an agreement with Nestlé Health Science to jointly commercialize SER-109, Seres’ investigational oral microbiome therapeutic…
Read More...

Following approval from the United States Bankruptcy Court for the District of Delaware, Mandos, LLC (Mandos) announced it has closed the acquisition of Adrabetadex (also known as…
Read More...

Bioasis Technologies Inc. and Oxyrane UK Ltd. are pleased to announce the initiation of a research collaboration. Bioasis is a pre-clinical, research-stage biopharmaceutical company…
Read More...

Apellis Pharmaceuticals, Inc. and Beam Therapeutics Inc. announced an exclusive five-year research collaboration focused on the use of Beam’s proprietary base editing technology to…
Read More...

OnCusp Therapeutics a global biopharmaceutical company focused on translating cutting-edge research assets into innovative oncology therapeutics, announced that it has officially…
Read More...

Gavi, the Vaccine Alliance announced that it had signed an advance purchase agreement (APA) with Clover Biopharmaceuticals for its SCB-2019 protein-based adjuvanted vaccine candidate…
Read More...

Altimmune, Inc. a clinical-stage biopharmaceutical company, today provided an update on its AdCOVID investigational vaccine for the prevention of COVID-19. The Company also provided an…
Read More...

FUJIFILM Corporation announced a ¥90 Billion Yen (~$850 Million USD) investment package to accelerate the growth of its core Bio CDMO subsidiary, FUJIFILM Diosynth Biotechnologies.…
Read More...

Aragen Life Sciences (formerly GVK BIO), a leading Contract Research and Development Organization, headquartered out of Hyderabad, India, announces an expansion of their discovery…
Read More...

Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, received a positive opinion…
Read More...

RedHill Biopharma Ltd. a specialty biopharmaceutical company, today announced preliminary results of a new preclinical study showing potent inhibition of COVID-19 variants of concern by…
Read More...